{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:48:31Z","timestamp":1782373711834,"version":"3.54.5"},"reference-count":0,"publisher":"AME Publishing Company","issue":"3","content-domain":{"domain":["amegroups.com"],"crossmark-restriction":false},"short-container-title":["Chin Clin Oncol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.21037\/cco-2026-1-0004","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T07:22:35Z","timestamp":1779348155000},"page":"53-53","update-policy":"https:\/\/doi.org\/10.21037\/ame_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adjuvant CDK4\/6 inhibitors and novel therapies in early breast cancer: lessons from monarchE overall survival data"],"prefix":"10.21037","volume":"15","author":[{"given":"Tatsunori","family":"Shimoi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8611","published-online":{"date-parts":[[2026,6]]},"container-title":["Chinese Clinical Oncology"],"original-title":[],"link":[{"URL":"https:\/\/cco.amegroups.com\/article\/download\/153911\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:14:51Z","timestamp":1782371691000},"score":1,"resource":{"primary":{"URL":"https:\/\/cco.amegroups.com\/article\/view\/153911\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]},"published-print":{"date-parts":[[2026,6]]}},"URL":"https:\/\/doi.org\/10.21037\/cco-2026-1-0004","relation":{},"ISSN":["2304-3865","2304-3873"],"issn-type":[{"value":"2304-3865","type":"print"},{"value":"2304-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}